
Opinion|Podcasts|November 30, 2023
Novel Investigational Approaches for the Treatment of Neovascular AMD
Listen
0:00 / 0:00
Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Advertisement
1:00 Retina specialists’ wish list for innovative therapies
6:40 Home OCT
8:43 Extending treatment intervals beyond four months
9:40 Therapies in the pipeline
15:00 Need for long-term retinal fluid suppression
16:00 Gene therapy
22:00 Helping patients facing end-stage vision loss
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
AIRCULES: Lunsekimig Benefit Scales With Severity, With Njira Lugogo, MD
2
What Baseline Disease Severity Hides in PsA Trial Data, With David Oberlin, MD
3
KT-621 Achieves Deep STAT6 Degradation, Initial Respiratory, Skin Gains
4
ESC 2026 Recap: 5 Practice-Changing Trials to Know
5






























































